Learn More
Medchemexpress LLC 8-chloro-11-(4-ethylpiperazin-1-yl)-1-fluoro-5H-dibenzo[b,e]diazepine | 2369979-67-7 | 99.5% | 358.84 g/mol | C19H20ClFN4 | 5 MG

Supplier: Medchemexpress LLC HY1318915MG
A brain-penetrant DREADD agonist research compound with low-nanomolar activity at engineered muscarinic receptors. It demonstrates selective displacement of radioligand binding in brain tissue and is supplied as a high-purity solid or as ready-to-use DMSO solutions for research applications. For research use only; not for human or clinical use.
- Potent agonist at hM3Dq (EC50 ≈ 5 nM) and hM4Di (EC50 ≈ 0.5 nM).
- Brain-penetrant with selective displacement of [3H]clozapine binding in brain tissue.
- High purity solid (≈99.5%) and available as 10 mM DMSO solutions for convenience.
- Suitable for in vivo and in vitro DREADD activation and imaging studies.
- Provided for research use only; not intended for human or clinical applications.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.